Impact Capital Partners’s Boston Scientific BSX Stock Holding History

Impact Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,298	Closed	-$314K	–	278
2025 Q4	$314K	Buy	3,298 +66	+2%	+$6.47K	0.09%	208
2025 Q3	$316K	Sell	3,232 -76	-2%	-$7.87K	0.1%	204
2025 Q2	$355K	Buy	3,308 +119	+4%	+$12K	0.12%	187
2025 Q1	$322K	Sell	3,189 -84	-3%	-$8.46K	0.12%	188
2024 Q4	$292K	Buy	+3,273	New	+$288K	0.1%	205

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Impact Capital Partners's BSX Position: Q1 2026 in Review

Impact Capital Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,298 shares — an estimated $314K sold.

Impact Capital Partners first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $355K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Impact Capital Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Impact Capital Partners sold 3,298 Boston Scientific shares in Q1 2026, an estimated $314K.
Impact Capital Partners first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
Impact Capital Partners's Boston Scientific position peaked at $355K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Impact Capital Partners's 13F filing for Q1 2026, filed 10 Apr 2026.